Information Collection Request

Follow-up of Kidney Cancer Patients from the Central European Multicenter Case-Control Study (CEERCC) (NCI)

ICR 200901-0925-004 · OMB 0925-0599 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Form 2 Abstraction Form for Physicians (CEERCC) Form New Available
Form 1 Lifestyle Questionnaire for Patients or Next-of-Kin (CEERCC) Form New Repair queued
Attach 4_REVISED_Privacy act Memo.doc Supplementary Document Uploaded 2009-05-07 Repair queued
CEERCC.Survival SSB_10.10.08.docx Supporting Statement B Uploaded 2009-01-02 Available
Attach 8_Power for Sample Size.docx Supplementary Document Uploaded 2009-01-02 Available
Attach 5_ConsentForms.docx Supplementary Document Uploaded 2009-01-02 Repair queued
Attach 4_Privacy act Memo.doc Supplementary Document Uploaded 2009-01-02 Available
Attach 1_CEERCC manuscripts.docx Supplementary Document Uploaded 2009-01-02 Available
Attach 3_IRB Approval.pdf Supplementary Document Uploaded 2009-01-02 Available
Attach 2_IRB Protocol.03.16.08.docx Supplementary Document Uploaded 2009-01-02 Available
SSA_REVISED_3-27-09.doc Supporting Statement A Uploaded 2009-05-07 Repair queued
IC Document Collections
ICR Details
0925-0599 200901-0925-004
Historical Active
HHS/NIH
Follow-up of Kidney Cancer Patients from the Central European Multicenter Case-Control Study (CEERCC) (NCI)
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 05/20/2009
Retrieve Notice of Action (NOA) 01/13/2009
Approved consistent with revisions uploaded on 5/7/2009.
  Inventory as of this Action Requested Previously Approved
05/31/2011 24 Months From Approved
450 0 0
296 0 0
0 0 0

The purpose of the "Follow-up of Kidney Cancer Patients from the Central European Multicenter Case-Control Study" is to obtain information on the 5-year survival status of kidney cancer patients that were enrolled in a Central European Case-control Study of Kidney Cancer that was conducted between 2001-2004. This study is needed to collect additional information since initial diagnosis so that we can identify additional factors that may pertain to or modify disease outcome. The information will be used to identify and disseminate information that can distinguish determinants of kidney cancer survival, to aid in the prevention and treatment of cancer recurrence and progression. The respondents will include 1100 patients (or next-of-kin, if the patients are deceased) that were deemed histologically confirmed kidney cancer cases and that had participated in an earlier case-control study. Additionally, 20 physicians will be employed to abstract hospital records, pathology reports and treatment information.

US Code: 42 USC 413(285a-2) Name of Law: Public Health Service Act
   US Code: 42 USC 412(285a-1) Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  73 FR 65387 11/03/2008
74 FR 1697 01/13/2009
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 450 0 0 450 0 0
Annual Time Burden (Hours) 296 0 0 296 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new collection of information.

$164,880
Yes Part B of Supporting Statement
No
Uncollected
Uncollected
No
Uncollected
Mikia Currie 3014350941

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/13/2009